SCHEMBL4982274

SCHEMBL4982274

C=CCc1c(C#N)cccc1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
GAA P10253 2/20 0.44
KDM4E B2RXH2 2/20 0.44
IMPDH2 P12268 1/20 0.44
IMPDH1 P20839 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.42
POLB P06746 2/20 0.41
HPGD P15428 1/20 0.41
PPARG P37231 1/20 0.40
PPARD Q03181 1/20 0.40
PPARA Q07869 1/20 0.40
TSHR P16473 1/20 0.39
AR P10275 2/20 0.38
ACHE P22303 2/20 0.37
BCHE P06276 1/20 0.37
HTR2A P28223 1/20 0.37
CYP3A4 P08684 1/20 0.37
ALOX5 P09917 1/20 0.37
PTGS1 P23219 1/20 0.37
TRPM8 Q7Z2W7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2845228 0.82 ALDH1A1 (0.53) ALDH1A1GAAKDM4ESMN1; SMN2POLB
SCHEMBL16884618 0.80 POLB (0.46) ALDH1A1GAAKDM4EIMPDH2IMPDH1
SCHEMBL11362823 0.78 POLB (0.45) ALDH1A1GAAKDM4EIMPDH2IMPDH1
SCHEMBL23860831 0.78 POLB (0.45) ALDH1A1GAAKDM4EIMPDH2IMPDH1
SCHEMBL29779908 0.78 POLB (0.45) ALDH1A1GAAKDM4EIMPDH2IMPDH1
SCHEMBL28338628 0.76 ALDH1A1 (0.48) ALDH1A1GAAKDM4ESMN1; SMN2POLB
SCHEMBL18984961 0.76 ALDH1A1 (0.48) ALDH1A1GAAKDM4ESMN1; SMN2POLB
SCHEMBL12327826 0.76 ALDH1A1 (0.51) ALDH1A1GAAKDM4ESMN1; SMN2POLB
SCHEMBL2170193 0.76 GABRA1 (0.43) ALDH1A1GAAKDM4ESMN1; SMN2HPGD
SCHEMBL2479613 0.75 ALDH1A1 (0.52) ALDH1A1GAAKDM4EPOLBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080119518-A1 1-(Piperidin-4- Yl)-1H-Indole Derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-05-22 US disclosed
EP-1847535-A1 1-(PIPERIDIN-4-YL)-1H-INDOLE DERIVATIVE Eisai R&D Management Co., Ltd. (JP) 2007-10-24 EP disclosed
US-6380436-B1 REACTING 4-TRIFLUOROMETHYLBENZONITRILE WITH GRIGNARD REAGENT SUN PHARMACEUTICAL INDUSTRIES LTD. (IN) 2002-04-30 US disclosed
WO-1999058485-A1 A PROCESS FOR THE SYNTHESIS OF ALKOXYALKYL (TRIFLUOROMETHYLPHENYL) METHANONES SUN PHARMACEUTICALS INDUSTRIES LTD. (IN) 1999-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119518-A1 1-(Piperidin-4- Yl)-1H-Indole Derivatives TPH1, HTR1D, HTR1B ALDH1A1 91/4885GAA 4739/4885KDM4E 1637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.